ArticleTrials2026
Evaluating the impacts of piperonyl butoxide-treated ceiling nets on malaria risk among high-risk populations with limited access to conventional LLINs in Homa Bay Country, Kenya: study protocol for a household randomized control trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionProgress in reducing the global malaria burden has stalled since 2015, with increases in malaria incidence and mortality reported in many African countries after 2020. In 2021, the WHO issued a conditional recommendation for house screening, including windows, ceilings, doors, and eave spaces, as a complementary intervention. However, evidence gaps remain, particularly regarding its effectiveness in combination with or as an alternative to long-lasting insecticide-treated nets (LLINs). This trial aims to evaluate the piperonyl butoxide-pyrethroid (PBO)-ceiling nets, a novel house screening tool covering ceilings, among high-risk households in Kenya with poor use of LLINs.
methodsThis trial includes both superiority and non-inferiority comparisons. Superiority comparisons will evaluate whether the combination of PBO-ceiling nets and PBO-LLINs provides greater protection than either intervention alone. Non-inferiority comparisons will assess whether PBO-ceiling nets alone are not inferior to PBO-LLINs alone in reducing malaria infection prevalence and entomological indicators. In Homa Bay County, Kenya, 500 households will be randomized into three arms: (1) receiving PBO-ceiling nets, (2) receiving PBO-LLINs at a ratio of one net per two household members, and (3) receiving both PBO-ceiling nets and PBO-LLINs. The primary outcome is the prevalence of Plasmodium infections by PCR among all age groups at 12 months post-intervention. Secondary outcomes include entomological indicators, such as the density of primary malaria vectors sampled using CDC light traps. DISCUSSION: This trial addresses key evidence gaps related to housing modifications for malaria prevention by evaluating the effectiveness of PBO-ceiling nets among high-risk populations with limited access to conventional LLINs. Although household-level randomization may limit the ability to capture potential spillover effects and introduce challenges such as open-label and observer biases, several measures have been incorporated to mitigate these risks, including frequent adherence reminders and blinding of laboratory and data analysis staff. Despite these limitations, the study is expected to generate important epidemiological and entomological data that will contribute to the evidence base for novel vector control strategies in malaria-endemic regions.
trial registrationPACTR202506499755138. Registered on June 20, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.